Public Profile

Warner Chilcott plc

Warner Chilcott plc, a prominent player in the pharmaceutical industry, is headquartered in Ireland (IE) and operates extensively across North America and Europe. Founded in 2000, the company has established itself as a leader in the development and marketing of branded prescription pharmaceuticals, particularly in women's health, dermatology, and urology. With a focus on innovative products, Warner Chilcott offers a range of unique medications that address specific health needs, setting them apart in a competitive market. The company has achieved significant milestones, including strategic acquisitions that have expanded its product portfolio and market reach. Recognised for its commitment to quality and patient care, Warner Chilcott continues to strengthen its position as a trusted name in the pharmaceutical sector.

DitchCarbon Score

How does Warner Chilcott plc's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

35

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

30

Industry Benchmark

Warner Chilcott plc's score of 35 is higher than 66% of the industry. This can give you a sense of how well the company is doing compared to its peers.

66%

Let us know if this data was useful to you

Warner Chilcott plc's reported carbon emissions

Warner Chilcott plc, headquartered in Ireland (IE), currently does not have publicly available carbon emissions data or specific reduction targets. Without emissions figures, it is challenging to assess their carbon footprint or climate commitments. However, the company may be engaged in industry-standard practices aimed at reducing environmental impact, although specific initiatives or pledges have not been disclosed. As the pharmaceutical sector increasingly focuses on sustainability, Warner Chilcott's future commitments and actions in this area will be crucial for aligning with global climate goals.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Warner Chilcott plc's primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Warner Chilcott plc is in IE, which has a low grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Warner Chilcott plc is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Ferring Pharmaceuticals Inc.

US
Pharmaceutical Preparation Manufacturing
Updated 6 days ago

Teva Pharmaceuticals

IL
Pharmaceutical Preparation Manufacturing
Updated 6 days ago

Faes Farma

ES
Pharmaceutical Preparation Manufacturing
Updated 18 days ago

Tillotts Pharma AG

CH
Pharmaceutical Preparation Manufacturing
Updated 6 days ago

Johnson Matthey

GB
Chemicals nec
Updated 6 days ago

Noramco

US
Pharmaceutical Preparation Manufacturing
Updated 6 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers